Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis and Treatment of Extrapulmonary Tuberculosis

  • Lee, Ji Yeon (Department of Internal Medicine, National Medical Center)
  • Received : 2015.02.03
  • Accepted : 2015.03.03
  • Published : 2015.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Extrapulmonary tuberculosis (EPTB) constitutes about 20% of all cases of tuberculosis (TB) in Korea. Diagnosing EPTB remains challenging because clinical samples obtained from relatively inaccessible sites may be paucibacillary, thus decreasing the sensitivity of diagnostic tests. Whenever practical, every effort should be made to obtain appropriate specimens for both mycobacteriologic and histopathologic examinations. The measurement of biochemical markers in TB-affected serosal fluids (adenosine deaminase or gamma interferon) and molecular biology techniques such as polymerase chain reaction may be useful adjuncts in the diagnosis of EPTB. Although the disease usually responds to standard anti-TB drug therapy, the ideal regimen and duration of treatment have not yet been established. A paradoxical response frequently occurs during anti-TB therapy. It should be distinguished from other causes of clinical deterioration. Surgery is required mainly to obtain valid diagnostic specimens and to manage complications. Because smear microscopy or culture is not available to monitor patients with EPTB, clinical monitoring is the usual way to assess the response to treatment.

Keywords

References

  1. World Health Organization. Definitions and reporting framework for tuberculosis: 2013 revision (updated December 2014). Geneva: World Health Organization; 2013.
  2. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis in Korea, 2013. Cheongwon: Korea Centers for Disease Control and Prevention; 2014.
  3. Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 2009;64:1090-5. https://doi.org/10.1136/thx.2009.118133
  4. Canadian Thoracic Society and The Public Health Agency of Canada and Licensors. Canadian tuberculosis standards. 7th ed. Ottawa: Public Health Agency of Canada; 2013.
  5. Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected pulmonary involvement in extrapulmonary tuberculosis patients. Chest 2008;134:589-94. https://doi.org/10.1378/chest.08-0319
  6. Lee J, Lee SY, Choi KJ, Lim JK, Yoo SS, Lee SY, et al. Clinical Utility of CT-based bronchial aspirate TB-PCR for the rapid diagnosis of pleural tuberculosis. Tuberc Respir Dis 2013;75:150-6. https://doi.org/10.4046/trd.2013.75.4.150
  7. Conde MB, Loivos AC, Rezende VM, Soares SL, Mello FC, Reingold AL, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003;167:723-5. https://doi.org/10.1164/rccm.2111019
  8. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241:264-8. https://doi.org/10.1001/jama.1979.03290290032021
  9. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993;88:989-99.
  10. de Noronha AL, Bafica A, Nogueira L, Barral A, Barral-Netto M. Lung granulomas from Mycobacterium tuberculosis /HIV-1 co-infected patients display decreased in situ TNF production. Pathol Res Pract 2008;204:155-61. https://doi.org/10.1016/j.prp.2007.10.008
  11. Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996;23:146-58. https://doi.org/10.1093/clinids/23.1.146
  12. Valdes L, Alvarez D, San Jose E, Penela P, Valle JM, Garcia- Pazos JM, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998;158:2017-21. https://doi.org/10.1001/archinte.158.18.2017
  13. Kim DW, Jung SJ, Ha TK, Park HK. Individual and combined diagnostic accuracy of ultrasound diagnosis, ultrasoundguided fine-needle aspiration and polymerase chain reaction in identifying tuberculous lymph nodes in the neck. Ultrasound Med Biol 2013;39:2308-14. https://doi.org/10.1016/j.ultrasmedbio.2013.07.004
  14. Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis 2011;53:555-62. https://doi.org/10.1093/cid/cir454
  15. Chow KM, Chow VC, Hung LC, Wong SM, Szeto CC. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples. Clin Infect Dis 2002;35:409-13. https://doi.org/10.1086/341898
  16. Jeon D. Tuberculous pleurisy: an update. Tuberc Respir Dis 2014;76:153-9. https://doi.org/10.4046/trd.2014.76.4.153
  17. Ruan SY, Chuang YC, Wang JY, Lin JW, Chien JY, Huang CT, et al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax 2012;67:822-7. https://doi.org/10.1136/thoraxjnl-2011-201363
  18. Bielsa S, Palma R, Pardina M, Esquerda A, Light RW, Porcel JM. Comparison of polymorphonuclear- and lymphocyterich tuberculous pleural effusions. Int J Tuberc Lung Dis 2013;17:85-9. https://doi.org/10.5588/ijtld.12.0236
  19. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009;59:167-87. https://doi.org/10.1016/j.jinf.2009.06.011
  20. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003;7:777-86.
  21. Lee SJ, Kim HS, Lee SH, Lee TW, Lee HR, Cho YJ, et al. Factors influencing pleural adenosine deaminase level in patients with tuberculous pleurisy. Am J Med Sci 2014;348:362-5. https://doi.org/10.1097/MAJ.0000000000000260
  22. Abrao FC, de Abreu IR, Miyake DH, Busico MA, Younes RN. Role of adenosine deaminase and the influence of age on the diagnosis of pleural tuberculosis. Int J Tuberc Lung Dis 2014;18:1363-9. https://doi.org/10.5588/ijtld.14.0257
  23. Liao YJ, Wu CY, Lee SW, Lee CL, Yang SS, Chang CS, et al. Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol 2012;18:5260-5.
  24. Cho BH, Kim BC, Yoon GJ, Choi SM, Chang J, Lee SH, et al. Adenosine deaminase activity in cerebrospinal fluid and serum for the diagnosis of tuberculous meningitis. Clin Neurol Neurosurg 2013;115:1831-6. https://doi.org/10.1016/j.clineuro.2013.05.017
  25. Tuon FF, Higashino HR, Lopes MI, Litvoc MN, Atomiya AN, Antonangelo L, et al. Adenosine deaminase and tuberculous meningitis: a systematic review with meta-analysis. Scand J Infect Dis 2010;42:198-207. https://doi.org/10.3109/00365540903428158
  26. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a metaanalysis. J Clin Gastroenterol 2006;40:705-10. https://doi.org/10.1097/00004836-200609000-00009
  27. Tuon FF, Litvoc MN, Lopes MI. Adenosine deaminase and tuberculous pericarditis: a systematic review with metaanalysis. Acta Trop 2006;99:67-74. https://doi.org/10.1016/j.actatropica.2006.07.004
  28. Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007;131:1133-41. https://doi.org/10.1378/chest.06-2273
  29. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002;122:900-5. https://doi.org/10.1378/chest.122.3.900
  30. Manjunath N, Shankar P, Rajan L, Bhargava A, Saluja S, Shriniwas. Evaluation of a polymerase chain reaction for the diagnosis of tuberculosis. Tubercle 1991;72:21-7. https://doi.org/10.1016/0041-3879(91)90020-S
  31. Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007;11:1-196.
  32. Linasmita P, Srisangkaew S, Wongsuk T, Bhongmakapat T, Watcharananan SP. Evaluation of real-time polymerase chain reaction for detection of the 16S ribosomal RNA gene of Mycobacterium tuberculosis and the diagnosis of cervical tuberculous lymphadenitis in a country with a high tuberculosis incidence. Clin Infect Dis 2012;55:313-21. https://doi.org/10.1093/cid/cis401
  33. Trajman A, da Silva Santos Kleiz de Oliveira EF, Bastos ML, Belo Neto E, Silva EM, da Silva Lourenco MC, et al. Accuracy of polimerase chain reaction for the diagnosis of pleural tuberculosis. Respir Med 2014;108:918-23. https://doi.org/10.1016/j.rmed.2014.04.007
  34. Kim YW, Kwak N, Seong MW, Kim EC, Yoo CG, Kim YW, et al. Accuracy of the Xpert(R) MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea. Int J Tuberc Lung Dis 2015;19:81-6. https://doi.org/10.5588/ijtld.14.0500
  35. Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and metaanalysis. Eur Respir J 2014;44:435-46. https://doi.org/10.1183/09031936.00007814
  36. World Health Organization. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization; 2013.
  37. Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol 2012;65:456-66. https://doi.org/10.1111/j.1574-695X.2012.00972.x
  38. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect 2011;63:362-9. https://doi.org/10.1016/j.jinf.2011.06.010
  39. Shin JA, Chang YS, Kim HJ, Ahn CM, Byun MK. Diagnostic utility of interferon-gamma release assay in extrapulmonary tuberculosis. Diagn Microbiol Infect Dis 2015 Feb 14 [Epub]. http://dx.doi.org/10.1016/j.diagmicrobio.2015.02.002.
  40. Zhang L, Zhang Y, Shi X, Zhang Y, Deng G, Lalvani A, et al. Utility of T-cell interferon-gamma release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China. PLoS One 2014;9:e85030. https://doi.org/10.1371/journal.pone.0085030
  41. Zhou Q, Chen YQ, Qin SM, Tao XN, Xin JB, Shi HZ. Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011;16:473-80. https://doi.org/10.1111/j.1440-1843.2011.01941.x
  42. Park KH, Cho OH, Lee EM, Lee SO, Choi SH, Kim YS, et al. Tcell- based assays on cerebrospinal fluid and PBMCs for rapid diagnosis of TB meningitis in non-HIV patients. Eur Respir J 2012;39:768-70. https://doi.org/10.1183/09031936.00098111
  43. Kim SH, Cho OH, Park SJ, Lee EM, Kim MN, Lee SO, et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis 2010;50:1349-58. https://doi.org/10.1086/652142
  44. Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013;12:999-1010. https://doi.org/10.1016/S1474-4422(13)70168-6
  45. Lee JY, Kim SM, Park SJ, Lee SO, Choi SH, Kim YS, et al. A rapid and non-invasive 2-step algorithm for diagnosing tuberculous peritonitis using a T cell-based assay on peripheral blood and peritoneal fluid mononuclear cells together with peritoneal fluid adenosine deaminase. J Infect 2015;70:356-66. https://doi.org/10.1016/j.jinf.2014.09.012
  46. Biglino A, Crivelli P, Concialdi E, Bolla C, Montrucchio G. Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis. Infection 2008;36:601-4. https://doi.org/10.1007/s15010-008-7402-y
  47. Bathoorn E, Limburg A, Bouwman JJ, Bossink AW, Thijsen SF. Diagnostic potential of an enzyme-linked immunospot assay in tuberculous pericarditis. Clin Vaccine Immunol 2011;18:874-7. https://doi.org/10.1128/CVI.00031-11
  48. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2008.
  49. Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013;13:27-35. https://doi.org/10.1016/S1473-3099(12)70264-5
  50. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2014.
  51. Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993;87:621-3. https://doi.org/10.1016/S0954-6111(05)80265-3
  52. Park SH, Yang SK, Yang DH, Kim KJ, Yoon SM, Choe JW, et al. Prospective randomized trial of six-month versus ninemonth therapy for intestinal tuberculosis. Antimicrob Agents Chemother 2009;53:4167-71. https://doi.org/10.1128/AAC.00874-09
  53. Cho OH, Park KH, Park SY, Moon SM, Chong YP, Kim MN, et al. Drug-resistant extrapulmonary tuberculosis. Infect Chemother 2011;43:258-61.
  54. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:803-9. https://doi.org/10.1007/s10096-002-0821-2
  55. Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection 2013;41:537-43. https://doi.org/10.1007/s15010-012-0376-9
  56. American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003;52:1-77.
  57. Jeon K, Choi WI, An JS, Lim SY, Kim WJ, Park GM, et al. Paradoxical response in HIV-negative patients with pleural tuber culosis: a retrospective multicentre study. Int J Tuberc Lung Dis 2012;16:846-51. https://doi.org/10.5588/ijtld.11.0642
  58. Garg RK, Malhotra HS, Kumar N. Paradoxical reaction in HIV negative tuberculous meningitis. J Neurol Sci 2014;340:26-36. https://doi.org/10.1016/j.jns.2014.03.025
  59. Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, et al. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect 2009;59:56-61. https://doi.org/10.1016/j.jinf.2009.05.006
  60. Park KH, Lee MS, Lee SO, Choi SH, Kim YS, Woo JH, et al. Incidence and outcomes of paradoxical lymph node enlargement after anti-tuberculosis therapy in non-HIV patients. J Infect 2013;67:408-15. https://doi.org/10.1016/j.jinf.2013.07.022
  61. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51. https://doi.org/10.1056/NEJMoa040573
  62. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008;(1):CD002244.
  63. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002;(4):CD000526.
  64. Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med 2014;371:1121-30. https://doi.org/10.1056/NEJMoa1407380
  65. Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2007;(4):CD001876.
  66. Lai YF, Chao TY, Wang YH, Lin AS. Pigtail drainage in the treatment of tuberculous pleural effusions: a randomised study. Thorax 2003;58:149-51. https://doi.org/10.1136/thorax.58.2.149
  67. Chung CL, Chen CH, Yeh CY, Sheu JR, Chang SC. Early effective drainage in the treatment of loculated tuberculous pleurisy. Eur Respir J 2008;31:1261-7. https://doi.org/10.1183/09031936.00122207
  68. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005;112:3608-16. https://doi.org/10.1161/CIRCULATIONAHA.105.543066
  69. Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, et al. EAU guidelines for the management of genitourinary tuberculosis. Eur Urol 2005;48:353-62. https://doi.org/10.1016/j.eururo.2005.03.008
  70. van Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL. Shortening the duration of treatment for cervical tuberculous lymphadenitis. Eur Respir J 2000;15:192-5. https://doi.org/10.1183/09031936.00.15119200
  71. Jain AK, Sreenivasan R, Saini NS, Kumar S, Jain S, Dhammi IK. Magnetic resonance evaluation of tubercular lesion in spine. Int Orthop 2012;36:261-9. https://doi.org/10.1007/s00264-011-1380-x
  72. Joseffer SS, Cooper PR. Modern imaging of spinal tuberculosis. J Neurosurg Spine 2005;2:145-50. https://doi.org/10.3171/spi.2005.2.2.0145
  73. Youn JE, Park IB, Kwon SY, Kim JS, Byun KS, Bak YT, et al. Follow- up colonoscopy at 3 months of therapy in patients with tentative diagnosis of intestinal tuberculosis. Korean J Med 1996;50:227-33.
  74. Kim YS, Kim YH, Lee KM, Kim JS, Park YS; IBD Study Group of the Korean Association of the Study of Intestinal Diseases. Diagnostic guideline of intestinal tuberculosis. Korean J Gastroenterol 2009;53:177-86.

Cited by

  1. Hepatic and Intra-abdominal Tuberculosis: 2016 Update vol.18, pp.12, 2015, https://doi.org/10.1007/s11908-016-0546-5
  2. Extra-Pulmonary Tuberculosis and Its Surgical Treatment vol.17, pp.4, 2016, https://doi.org/10.1089/sur.2016.046
  3. A Rare Manifestation of Tuberculosis Presenting in the United States vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/8216040
  4. Clinical Applications of Interferon-gamma Release Assays vol.6, pp.1, 2015, https://doi.org/10.3343/lmo.2016.6.1.8
  5. A Severe Hepatotoxicity by Antituberculosis Drug, and its Recovery in Oriental Hospital vol.37, pp.2, 2015, https://doi.org/10.13048/jkm.16028
  6. Paradoxical response as a cervical lymph node enlargement after termination of anti-tuberculosis treatment in a patient with pulmonary tuberculosis vol.31, pp.1, 2015, https://doi.org/10.7180/kmj.2016.31.1.71
  7. Splenic tuberculosis in a patient with newly diagnosed advanced HIV infection vol.6, pp.None, 2016, https://doi.org/10.1016/j.idcr.2016.08.008
  8. En Plaque Tuberculoma: a Case Report vol.20, pp.3, 2015, https://doi.org/10.13104/imri.2016.20.3.200
  9. A prospective study on tubercular fistula in ano and its management vol.37, pp.3, 2017, https://doi.org/10.1016/j.jcol.2017.04.005
  10. Identification of Mycobacterium tuberculosis in Clinical Specimens of Patients Suspected of Having Extrapulmonary Tuberculosis by Application of Nested PCR on Five Different Genes vol.7, pp.None, 2015, https://doi.org/10.3389/fcimb.2017.00003
  11. Unique Chemokine Profiles of Lung Tissues Distinguish Post-chemotherapeutic Persistent and Chronic Tuberculosis in a Mouse Model vol.7, pp.None, 2015, https://doi.org/10.3389/fcimb.2017.00314
  12. Features of 921 Patients With Spinal Tuberculosis: A 16-Year Investigation of a General Hospital in Southwest China vol.40, pp.6, 2015, https://doi.org/10.3928/01477447-20171012-03
  13. Unusual Causes of Adenopathy in a Tropical Environment: About 3 Observations vol.7, pp.4, 2015, https://doi.org/10.4236/ojim.2017.74012
  14. Mycobacterium tuberculosis ESAT6 and CPF10 Induce Adenosine Deaminase 2 mRNA Expression in Monocyte-Derived Macrophages vol.80, pp.1, 2015, https://doi.org/10.4046/trd.2017.80.1.77
  15. Progression of Tuberculous Pleurisy: From a Lymphocyte-Predominant Free-Flowing Effusion to a Neutrophil-Predominant Loculated Effusion vol.80, pp.1, 2015, https://doi.org/10.4046/trd.2017.80.1.90
  16. Physical impairments and activity limitations experienced by people with tuberculosis : a scoping review protocol vol.15, pp.1, 2015, https://doi.org/10.11124/jbisrir-2016-002963
  17. Absorption, distribution and excretion of the anti‐tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis vol.38, pp.4, 2015, https://doi.org/10.1002/bdd.2064
  18. A 34-Year-Old Obese Woman with Rash, Finger Swelling and Fever vol.59, pp.None, 2015, https://doi.org/10.1016/j.ijid.2017.04.001
  19. Acerca de la tuberculosis extrapulmonar vol.26, pp.2, 2015, https://doi.org/10.1016/j.reper.2017.04.004
  20. Pancreatic mass in a 95-year-old male: A rare presentation of tuberculosis vol.3, pp.2, 2015, https://doi.org/10.4103/2455-5568.222477
  21. Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa vol.145, pp.12, 2017, https://doi.org/10.1017/s095026881700156x
  22. Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10 + Th17 CD4 T-cells differentiate latent from active tuberculosis vol.7, pp.None, 2015, https://doi.org/10.1038/s41598-017-10773-5
  23. Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system vol.8, pp.22, 2015, https://doi.org/10.1039/c8ra00984h
  24. Reactivation and Dissemination of Tuberculosis to Extrapulmonary Sites in Patients With Hematologic Malignancies vol.26, pp.1, 2015, https://doi.org/10.1097/ipc.0000000000000576
  25. Evaluation of Microscopy, Culture and PCR Assay in the Diagnosis of Extrapulmonary Tuberculosis vol.12, pp.2, 2018, https://doi.org/10.22207/jpam.12.2.49
  26. Analysis of Treatment and Prognosis of 863 Patients with Spinal Tuberculosis in Guizhou Province vol.2018, pp.None, 2015, https://doi.org/10.1155/2018/3265735
  27. Tuberculosis of the Spine (L5, S1) Secondary to Scrofuloderma with Viral Warts in a 15-Year-Old Male vol.7, pp.1, 2015, https://doi.org/10.4236/crcm.2018.71007
  28. Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections vol.10, pp.3, 2015, https://doi.org/10.1177/1756287217745772
  29. Delayed diagnosis of extrapulmonary tuberculosis presenting as fever of unknown origin in an intermediate-burden country vol.18, pp.None, 2015, https://doi.org/10.1186/s12879-018-3349-5
  30. Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion vol.13, pp.9, 2015, https://doi.org/10.2217/nnm-2017-0365
  31. Performance of the IS6110-TaqMan® assay in the diagnosis of extrapulmonary tuberculosis from different biological samples vol.51, pp.3, 2015, https://doi.org/10.1590/0037-8682-0372-2017
  32. Association between an Interleukin 4 Gene Polymorphism, rs2243268, and Urogenital Tuberculosis vol.13, pp.2, 2015, https://doi.org/10.14777/uti.2018.13.2.35
  33. Imaging manifestations of B-mode ultrasound combined with CT in tuberculous pleuritis patients and the diagnostic value vol.16, pp.3, 2015, https://doi.org/10.3892/etm.2018.6471
  34. Tuberculous peritonitis in children: Two case reports highlighting the important role of imaging ☆ vol.13, pp.4, 2015, https://doi.org/10.1016/j.radcr.2018.05.010
  35. Solitary Jejunal Tuberculosis with Intestinal Obstruction in an Immunocompetent Patient vol.93, pp.6, 2015, https://doi.org/10.3904/kjm.2018.93.6.556
  36. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13 vol.37, pp.6, 2015, https://doi.org/10.1080/07391102.2018.1462734
  37. Recurrent Episodes of Pericardial Effusion as Isolated Manifestation of Tuberculosis: Case Report vol.15, pp.1, 2015, https://doi.org/10.2174/1573405613666170619093338
  38. Evaluation of the Yield of Histopathology in the Diagnosis of Lymph Node Tuberculosis in Morocco, 2017: Cross-Sectional Study vol.5, pp.4, 2015, https://doi.org/10.2196/14252
  39. A case report of tuberculous empyema: A tricky disease vol.8, pp.3, 2015, https://doi.org/10.4103/ijmy.ijmy_110_19
  40. Primary Malignant Mesothelioma of the Peritoneum Mistaken for Peritoneal Tuberculosis due to Elevated Cancer Antigen 125 vol.74, pp.4, 2015, https://doi.org/10.4166/kjg.2019.74.4.232
  41. Identification and validation of l‐asparaginase as a potential metabolic target against Mycobacterium tuberculosis vol.120, pp.1, 2015, https://doi.org/10.1002/jcb.27169
  42. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis vol.103, pp.2, 2015, https://doi.org/10.1007/s00253-018-9518-z
  43. Tuberculosis Incidence and Factors Associated With Mortality Among Health Care Workers in Malaysia vol.31, pp.1, 2015, https://doi.org/10.1177/1010539518817980
  44. Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis vol.14, pp.4, 2015, https://doi.org/10.1371/journal.pone.0215647
  45. Clinical Characteristics and Treatment Outcomes of Definitive versus Standard Anti-Tuberculosis Therapy in Patients with Tuberculous Lymphadenitis vol.8, pp.6, 2015, https://doi.org/10.3390/jcm8060813
  46. Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study vol.57, pp.9, 2015, https://doi.org/10.1128/jcm.00614-19
  47. Pulmonary tuberculosis with rhinosinusal and otic manifestations - diagnostic challenge vol.9, pp.35, 2015, https://doi.org/10.2478/rjr-2019-0019
  48. microRNAs in Mycobacterial Infection: Modulation of Host Immune Response and Apoptotic Pathways vol.19, pp.5, 2015, https://doi.org/10.4110/in.2019.19.e30
  49. Laboratory tools for tuberculosis control in a setting with a high burden of HIV/AIDS vol.68, pp.11, 2015, https://doi.org/10.1099/jmm.0.001089
  50. Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya vol.19, pp.1, 2019, https://doi.org/10.1186/s12879-019-4540-z
  51. Controversies and Pitfalls in the Diagnosis of Extrapulmonary Tuberculosis with a Focus on Genital Tuberculosis vol.16, pp.2, 2015, https://doi.org/10.17925/use.2020.16.2.109
  52. Different Quantitative Interferon-γ Response in Active Tuberculosis of Various Primary Infection Sites vol.10, pp.1, 2015, https://doi.org/10.3343/lmo.2020.10.1.58
  53. Imaging and clinical features of breast tuberculosis: a review series of 62 cases vol.75, pp.7, 2015, https://doi.org/10.1016/j.crad.2020.03.017
  54. Direct and indirect patient costs of tuberculosis care in India vol.25, pp.7, 2015, https://doi.org/10.1111/tmi.13402
  55. Low body mass index has minimal impact on plasma levels of cytokines and chemokines in tuberculous lymphadenitis vol.20, pp.None, 2015, https://doi.org/10.1016/j.jctube.2020.100163
  56. The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study vol.15, pp.8, 2015, https://doi.org/10.1371/journal.pone.0237753
  57. Does Drug-Resistant Extrapulmonary Tuberculosis Hinder TB Elimination Plans? A Case from Delhi, India vol.5, pp.3, 2015, https://doi.org/10.3390/tropicalmed5030109
  58. Incidence, risk factors and clinical characteristics of extra‐pulmonary tuberculosis patients: a ten‐year study in the North of Iran vol.25, pp.9, 2015, https://doi.org/10.1111/tmi.13452
  59. In the Absence of Proof vol.383, pp.19, 2015, https://doi.org/10.1056/nejmcps2002083
  60. A retrospective study of tuberculosis prevalence amongst patients attending a tertiary hospital in Riyadh, Saudi Arabia vol.21, pp.None, 2020, https://doi.org/10.1016/j.jctube.2020.100185
  61. GeneXpert assay – A cutting-edge tool for rapid tissue diagnosis of tuberculous lymphadenitis vol.21, pp.None, 2015, https://doi.org/10.1016/j.jctube.2020.100204
  62. Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis vol.20, pp.None, 2015, https://doi.org/10.1186/s12879-019-4745-1
  63. False positive finding from malignancy-like lesions on FDG PET/CT: case report of tuberculosis patients vol.20, pp.None, 2015, https://doi.org/10.1186/s12880-020-00427-w
  64. Early diagnosis of miliary tuberculosis in a hemodialysis patient by combining two interferon-γ-release assays: a case report vol.21, pp.1, 2015, https://doi.org/10.1186/s12882-020-01875-w
  65. Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review vol.13, pp.1, 2020, https://doi.org/10.1186/s40545-020-00227-1
  66. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia vol.15, pp.12, 2015, https://doi.org/10.1371/journal.pone.0243493
  67. Tuberculosis diagnostics: overcoming ancient challenges with modern solutions vol.4, pp.4, 2015, https://doi.org/10.1042/etls20200335
  68. Performance Comparison of GeneXpert MTB/RIF and ProbeTec ET Tests for Rapid Molecular Diagnosis of Extrapulmonary Tuberculosis in a Low TB/MDR-TB Incidence Country vol.30, pp.3, 2015, https://doi.org/10.1159/000515254
  69. Tuberculoma mimicking postoperative VP shunt seeding of craniopharyngioma: A rare case report vol.12, pp.None, 2021, https://doi.org/10.25259/sni_606_2021
  70. Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing? vol.16, pp.1, 2015, https://doi.org/10.1371/journal.pone.0244785
  71. Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era vol.11, pp.None, 2015, https://doi.org/10.3389/fmicb.2020.618168
  72. The Distribution And Typological Classification Of Incidence/Mortality Rates And Dynamics Of Tuberculosis In Russia, 2006-2017 vol.14, pp.1, 2015, https://doi.org/10.24057/2071-9388-2020-202
  73. Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant vol.64, pp.8, 2021, https://doi.org/10.1021/acs.jmedchem.0c01833
  74. Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment vol.13, pp.5, 2015, https://doi.org/10.3390/pharmaceutics13050592
  75. Host biomarkers for monitoring therapeutic response in extrapulmonary tuberculosis vol.142, pp.None, 2021, https://doi.org/10.1016/j.cyto.2021.155499
  76. Molecular diagnostics for verification of pleural tuberculosis in Morocco vol.11, pp.3, 2021, https://doi.org/10.15789/2220-7619-mdo-1399
  77. Use of Rv0222-Rv2657c-Rv1509 Fusion Protein to Improve the Accuracy of an Antibody ELISA for Extra-Pulmonary Tuberculosis in Humans vol.10, pp.7, 2015, https://doi.org/10.3390/pathogens10070828
  78. Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis vol.65, pp.8, 2021, https://doi.org/10.1128/aac.02571-20
  79. Clinical Trial: Magnetoplasmonic ELISA for Urine-based Active Tuberculosis Detection and Anti-Tuberculosis Therapy Monitoring vol.7, pp.11, 2021, https://doi.org/10.1021/acscentsci.1c00948
  80. Evaluation of hypertonic saline-sodium hydroxide method for isolation of Mycobacterium tuberculosis on Lowenstein-Jensen medium vol.7, pp.2, 2021, https://doi.org/10.4103/jcrsm.jcrsm_6_21
  81. Disseminated tuberculosis with symptoms of decreased consciousness: A rare case in Indonesian male vol.73, pp.None, 2022, https://doi.org/10.1016/j.amsu.2021.103209